|
METTL13 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.42630004976263E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.34429999995878E-06 |
| Normal-vs-Stage2 |
5.6398000000013E-05 |
| Normal-vs-Stage3 |
6.42209996293275E-09 |
| Normal-vs-Stage4 |
2.97700000206902E-08 |
| Stage1-vs-Stage2 |
2.669000E-01 |
| Stage1-vs-Stage3 |
9.018400E-03 |
| Stage1-vs-Stage4 |
1.816300E-02 |
| Stage2-vs-Stage3 |
4.309000E-01 |
| Stage2-vs-Stage4 |
4.233800E-01 |
| Stage3-vs-Stage4 |
9.999800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.3852001463971E-10 |
| Normal-vs-AfricanAmerican |
4.799900E-03 |
| Normal-vs-Asian |
6.203600E-01 |
| Caucasian-vs-AfricanAmerican |
2.310800E-01 |
| Caucasian-vs-Asian |
2.798200E-02 |
| AfricanAmerican-vs-Asian |
1.209790E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.03980002386095E-09 |
| Normal-vs-Female |
1.67149999996674E-06 |
| Male-vs-Female |
1.613040E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.185830E-02 |
| Normal-vs-Age(41-60Yrs) |
3.95529999863697E-08 |
| Normal-vs-Age(61-80Yrs) |
6.19459999962046E-08 |
| Normal-vs-Age(81-100Yrs) |
1.539210E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.211000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.492200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.255800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.415600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.465400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.030400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.847000E-01 |
| Normal-vs-Grade 2 |
9.22170000028366E-07 |
| Normal-vs-Grade 3 |
6.94330004602506E-09 |
| Normal-vs-Grade 4 |
1.21400000052674E-07 |
| Grade 1-vs-Grade 2 |
7.548300E-02 |
| Grade 1-vs-Grade 3 |
3.045700E-02 |
| Grade 1-vs-Grade 4 |
1.540380E-02 |
| Grade 2-vs-Grade 3 |
1.608150E-01 |
| Grade 2-vs-Grade 4 |
2.868300E-02 |
| Grade 3-vs-Grade 4 |
2.599200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.2851000000278E-06 |
| Normal-vs-ccB subtype |
1.04299999970081E-07 |
| ccA subtype-vs-ccB subtype |
2.252800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.44250000014779E-08 |
| Normal-vs-N1 |
4.913600E-01 |
| N0-vs-N1 |
1.796990E-01 |
|
|
